Live tape
Top 8, mentions 7d14,345GOOGL2,871 mentions▲ +0.04NVDA2,218 mentions▲ +0.05AMD1,940 mentions▲ +0.08QQQ1,752 mentions▲ +0.05AAPL1,729 mentions▲ +0.05SPY1,562 mentions▲ +0.06TSLA1,165 mentions▲ +0.06SPCX1,108 mentions▲ +0.05

Equity · Healthcare

PCVX

NASDAQ

Vaxcyte (PCVX)

63.88 USD +3.22% vs prior close Nov 6, 2026
Vaxcyte, Inc. price graph
29 sessions
75 55 29 Sep 6 Nov

The line runs 56.71 USD on 29 September through 63.88 USD on 6 November, on a scale from 55 to 75. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
10.1B USD
EPS, diluted, year to Dec 2025
−5.63 USD
52-week range
40 USD – 71.34 USD
Avg volume
197.4K

as of Nov 6, 2026

Have Vaxcyte (PCVX) insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Vaxcyte insiders reported 8 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Jan 2026, show no open-market purchase.

Form 4, 90 days to 9 Nov 2026, newest reported trade 2 Nov 2026

Buys 0Sells 8Net sold $4.03MOther filings 22

Have Vaxcyte (PCVX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Nov 2026Wassil JimEVP, Chief Scientific Ofc, COOSell2,250137K USD
02 Nov 2026Cowan ElviaSVP, Finance & CAOSell3,000183K USD
05 Oct 2026Cowan ElviaSVP, Finance & CAOSell19,0001.6M USD
05 Oct 2026Wassil JimEVP, Chief Scientific Ofc, COOSell18,0001.6M USD
01 Oct 2026Wassil JimEVP, Chief Scientific Ofc, COOSell2,250128K USD
09 Sep 2026Wassil JimEVP, Chief Scientific Ofc, COOSell1,33479K USD
04 Sep 2026Wassil JimEVP, Chief Scientific Ofc, COOSell1,38184K USD
01 Sep 2026Wassil JimCHIEF OPERATING OFFICERSell3,477212K USD
Sold8 open-market sales50,692$4.03M
22 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Vaxcyte (PCVX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Nov 2026Wassil JimEVP, Chief Scientific Ofc, COOOption exercise2,25012K USD
02 Nov 2026Cowan ElviaSVP, Finance & CAOOption exercise3,00078K USD
05 Oct 2026Cowan ElviaSVP, Finance & CAOOption exercise19,000492K USD
05 Oct 2026Wassil JimEVP, Chief Scientific Ofc, COOOption exercise18,00096K USD
01 Oct 2026Wassil JimEVP, Chief Scientific Ofc, COOOption exercise2,25012K USD
08 Sep 2026Cowan ElviaSVP, Finance & CAOTax withheld1,32780K USD
08 Sep 2026Dhaliwal Harpreet S.Chief Technical Ops OfficerTax withheld7,651462K USD
08 Sep 2026GUGGENHIME ANDREWPRESIDENT AND CFOTax withheld7,155432K USD
08 Sep 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERTax withheld17,0561.0M USD
08 Sep 2026Wassil JimEVP, Chief Scientific Ofc, COOTax withheld5,459330K USD
04 Sep 2026Jodar LuisChief Medical OfficerAward52,632
02 Sep 2026Cowan ElviaSVP, Finance & CAOTax withheld32620K USD

Showing the 12 most recent of 22 compensation filings in this window. The figures above count all of them.

Which funds hold Vaxcyte (PCVX)?

8 of the 45 institutional funds we track reported a Vaxcyte position for the quarter ended 30 Jun 2026 — a combined 239.0M USD; the latest of those filings landed 14 Aug 2026.

Form 13F

Which funds hold Vaxcyte (PCVX)?
FundPositionSharesValueShares q/q
D. E. Shaw & Co.Trimmed1,901,872110.6M USD−33.6%
Maverick CapitalHeld (±25%)1,613,24293.8M USD+17.1%
Two Sigma InvestmentsAdded273,87615.9M USD+146.0%
Millennium ManagementTrimmed136,6257.9M USD−53.5%
Man GroupAdded81,6324.7M USD+323.9%
Bridgewater AssociatesAdded50,2172.9M USD+289.2%
AQR Capital ManagementAdded34,5632.0M USD+35.8%
Renaissance TechnologiesTrimmed19,6341.1M USD−64.1%
Balyasny Asset ManagementExited
Baupost GroupExited

Have members of Congress traded Vaxcyte (PCVX)?

The most recent congressional trade disclosed in Vaxcyte is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 16 Jul 2026.

STOCK Act disclosures

Have members of Congress traded Vaxcyte (PCVX)?
TradedMemberTypeAmountFiled after
16 Jul 2026Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD50 days
13 May 2026Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD26 days
28 Apr 2025Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD8 days
15 Apr 2025Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD21 days
05 Mar 2025Jefferson Shrevehouse · Republican–INSale15K USD–50K USD37 days
12 Dec 2022Sara Jacobshouse · Democrat–CASale1K USD–15K USD39 days
08 Nov 2022Sara Jacobshouse · Democrat–CAPurchase1K USD–15K USD34 days

What has been filed or recorded for Vaxcyte (PCVX)?

The filings we hold for Vaxcyte, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Vaxcyte (PCVX)?
And
13 Oct 2026Fails to deliverShares failed to deliver11,553 shares816K USD notional · 0.008% of shares out
09 Oct 2026Fails to deliverShares failed to deliver326 shares21K USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver461,970 shares30.9M USD notional · 0.310% of shares out
07 Oct 2026Fails to deliverShares failed to deliver53 shares4K USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −1.99 USD
30 Sep 2026FinancialsTotal assets3.0B USDat period end
30 Sep 2026FinancialsTotal equity2.5B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −1.97 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −2.30 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −5.63 USD
31 Dec 2025FinancialsNet income−766.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−5.63 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −1.56 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −1.22 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −1.04 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −3.80 USD

Vaxcyte (PCVX): frequently asked questions

From live data
63.88

What did Vaxcyte shares close at?

Vaxcyte closed at 63.88 USD on 6 Nov 2026, up 3.22% on the close before. That is the end-of-day price from Finazon, not a live quote.

10.1B

What is Vaxcyte’s market cap?

Vaxcyte is worth 10.1B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.

8 sales

Have Vaxcyte insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Vaxcyte insiders reported 8 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Jan 2026, show no open-market purchase. A further 22 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

8 of 45

Which funds own Vaxcyte?

8 of the 45 funds we track reported a Vaxcyte position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Maverick Capital and Two Sigma Investments. See Funds

7 trades

Have members of Congress traded Vaxcyte?

Yes. 7 trades in Vaxcyte appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 16 Jul 2026, filed 4 Sep 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

−1.99

When did Vaxcyte last report earnings?

Vaxcyte last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.99 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings